Echographic assessment of age‐dependent variations of skin thickness: a study on 162 subjects C Lasagni, S Seidenari Skin Research and Technology 1 (2), 81-85, 1995 | 77 | 1995 |
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience P Gisondi, S Piaserico, L Naldi, P Dapavo, A Conti, P Malagoli, ... Journal of Allergy and Clinical Immunology 147 (2), 558-560. e1, 2021 | 63 | 2021 |
Pruritus characteristics in a large Italian cohort of psoriatic patients G Damiani, S Cazzaniga, RR Conic, L Naldi, Psocare Registry Network, ... Journal of the European Academy of Dermatology and Venereology 33 (7), 1316-1324, 2019 | 58 | 2019 |
Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: a multicentric retrospective analysis V Di Lernia, L Stingeni, V Boccaletti, PG Calzavara Pinton, C Guarneri, ... Journal of Dermatological Treatment 27 (5), 395-398, 2016 | 56 | 2016 |
Evolution of COVID‐19 infection in four psoriatic patients treated with biological drugs A Conti, C Lasagni, L Bigi, G Pellacani Journal of the European Academy of Dermatology and Venereology 34 (8), e360, 2020 | 53 | 2020 |
Effectiveness and safety of acitretin in children with plaque psoriasis: a multicenter retrospective analysis V Di Lernia, D Bonamonte, C Lasagni, A Belloni Fortina, S Cambiaghi, ... Pediatric Dermatology 33 (5), 530-535, 2016 | 51 | 2016 |
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry P Gisondi, S Cazzaniga, S Chimenti, M Maccarone, M Picardo, ... British Journal of Dermatology 172 (6), 1613-1620, 2015 | 51 | 2015 |
Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis: consensus recommendations P Gisondi, M Talamonti, A Chiricozzi, S Piaserico, P Amerio, A Balato, ... Dermatology and Therapy 11, 235-252, 2021 | 49 | 2021 |
Characterization of hidradenitis suppurativa phenotypes: a multidimensional latent class analysis of the National Italian Registry IRHIS S Cazzaniga, E Pezzolo, V Bettoli, D Abeni, AV Marzano, A Patrizi, ... Journal of Investigative Dermatology 141 (5), 1236-1242. e1, 2021 | 32 | 2021 |
Adalimumab in severe plaque psoriasis of childhood: a multi‐center, retrospective real‐life study up to 52 weeks observation V Di Lernia, L Bianchi, C Guerriero, L Stingeni, P Gisondi, A Filoni, ... Dermatologic Therapy 32 (6), e13091, 2019 | 29 | 2019 |
Management of patients with psoriasis treated with biological drugs needing a surgical treatment A Fabiano, C De Simone, P Gisondi, S Piaserico, C Lasagni, G Pellacani, ... Drug Development Research 75, S24-S26, 2014 | 28 | 2014 |
Chronic kidney disease in psoriasis: a cohort study A Conti, L Giovannini, VD Mandel, G Odorici, C Lasagni, L Bigi, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (5), 438-445, 2020 | 27 | 2020 |
Integrated metabolomic analysis and cytokine profiling define clusters of immuno-metabolic correlation in new-onset psoriasis E Tarentini, G Odorici, V Righi, A Paganelli, L Giacomelli, V Mirisola, ... Scientific reports 11 (1), 10472, 2021 | 23 | 2021 |
Psoriasis and pregnancy outcomes in biological therapies: a real-life, multi-centre experience G Odorici, V Di Lernia, F Bardazzi, M Magnano, S Di Nuzzo, C Cortelazzi, ... Journal of the European Academy of Dermatology and Venereology 33 (10), e374 …, 2019 | 20 | 2019 |
Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies C Lasagni, L Bigi, A Conti, G Pellacani Journal of Dermatological Treatment 29 (sup2), 5-8, 2018 | 16 | 2018 |
Management of long‐term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting A Conti, S Piaserico, P Gisondi, G Odorici, G Galdo, C Lasagni, ... Dermatologic Therapy 30 (5), e12503, 2017 | 16 | 2017 |
Acute maculopapular eruption in Covid‐19 patient: a case report E Rossi, C Lasagni, M Trakatelli, S Wertzberger Rowan, C Magnoni Dermatologic Therapy 33 (6), e13812, 2020 | 14 | 2020 |
Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience F Bardazzi, F Viviani, Y Merli, V Di Lernia, F Peccerillo, A Conti, C Lasagni, ... Expert Opinion on Biological Therapy 22 (12), 1561-1566, 2022 | 13 | 2022 |
A real‐life experience of psoriatic patients with history of cancer treated with biological drugs. G Odorici, C Lasagni, L Bigi, G Pellacani, A Conti Journal of the European Academy of Dermatology & Venereology 33 (12), 2019 | 13 | 2019 |
Hidradenitis suppurativa in a large cohort of italian patients: evaluation of the burden of disease G Fabbrocini, G Ruina, G Giovanardi, V Dini, B Raone, M Venturini, ... Dermatology 238 (3), 487-497, 2022 | 12 | 2022 |